The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Hi Obelix, I’ve been involved in a number of insurance and fiduciary buy-outs and the due diligence process is rarely a smooth ride. Even if the deal is agreed in principal a small issue can add on weeks/a month etc. Obviously my own personal experiences haven’t been pharmas or public companies however I think it’s a similar situation for both imo. I’d imagine that given its publicly listed and that val401 wants to get phase III started ASAP that there would be some urgency to get the deal done. Let’s just hope they’ve got through the nitty gritty and are putting pen to paper. Geecee
Bwgs, glad to see some optimism! I like to consider both sides but would much rather think positively. We’ll see next week whether the short term effect of this tr1 is influential, if not then there’s still reason to be hopeful of a gain medium to long term given the current status of Val201 and Val401. Geecee
Hi Bwgs, fair enough - I just didn’t want to raise to the hype and be presumptuous that this stock will certainly rise due to his investment although I am hopeful. Maybe it was a bit too strong to suggest insider information but with aim it’s hard to always hold its integrity. Wish you all the best mate, Geecee
Not accusing him of inside information, just now he’s increased his investment some people see that as a sign of things to come - if he is an omen (as his previous investments seem to be touted) it would only be from very good research or information unknown to the masses. Either way I’m here for the long haul. Good luck all